Unknown Author
January 23, 2026
Sidley Represents Carlin Consumer Health in Its Acquisition of Penetrex

2 min
AI-made summary
- Sidley advised Carlin Consumer Health in its acquisition of Penetrex, a joint and muscle care consumer brand, from Wellbeam Consumer Health
- Following the transaction, Penetrex will be integrated into Carlin’s portfolio
- Carlin is a consumer health company focused on acquiring over-the-counter brands
- The Sidley legal team involved attorneys from various practice areas, including technology, private equity, litigation, employee benefits, healthcare, insurance, investment funds, labor, privacy, real estate, and tax.
Sidley represented Carlin Consumer Health (Carlin) in its acquisition of PENETREX (Penetrex), a joint and muscle care consumer brand, from Wellbeam Consumer Health. Penetrex will now become a brand within the Carlin Consumer Health portfolio as a part of the transaction. Carlin is a consumer health business positioned to acquire over-the-counter brands.
The Sidley team was led by Asher Rubin (Technology and Life Sciences Transactions) and Zachary Shub-Essig (Private Equity), and included Daniel E. Gessner (Private Equity); Lauren Grau, Dusan Clark, and Dina M.P. Kang (Technology and Life Sciences Transactions); Rollin A. Ransom and Ernesto R. Claeyssen (Commercial Litigation and Disputes); Amy P. Lally (Consumer Class Actions, ERISA and Insurance Litigation); Stacy Crosnicker and Alexandra B. Green (Employee Benefits and Executive Compensation); Greer O. Lautrup, Diane C. McEnroe, and Susan Stolzer (Food, Drug and Medical Device); Alison C. Boren, Christopher Gleason, Pietro Fontana, and Kyle Gromann (Global Finance); Donielle McCutcheon and Meghan F. Weinberg (Healthcare); Scott J.F. Goldstein (Insurance); Carla G. Teodoro (Investment Funds); Eric Kauffman (Labor and Employment); Ash Nagdev (Privacy and Cybersecurity); Keith Hayden Del Prete and Samuel Deddeh (Real Estate); and Idan Netser and Alvin Wang (Tax).~~Sidley represented Carlin Consumer Health (Carlin) in its acquisition of PENETREX (Penetrex), a joint and muscle care consumer brand, from Wellbeam Consumer Health. Penetrex will now become a brand within the Carlin Consumer Health portfolio as a part of the transaction. Carlin is a consumer health business positioned to acquire over-the-counter brands.
The Sidley team was led by Asher Rubin (Technology and Life Sciences Transactions) and Zachary Shub-Essig (Private Equity), and included Daniel E. Gessner (Private Equity); Lauren Grau, Dusan Clark, and Dina M.P. Kang (Technology and Life Sciences Transactions); Rollin A. Ransom and Ernesto R. Claeyssen (Commercial Litigation and Disputes); Amy P. Lally (Consumer Class Actions, ERISA and Insurance Litigation); Stacy Crosnicker and Alexandra B. Green (Employee Benefits and Executive Compensation); Greer O. Lautrup, Diane C. McEnroe, and Susan Stolzer (Food, Drug and Medical Device); Alison C. Boren, Christopher Gleason, Pietro Fontana, and Kyle Gromann (Global Finance); Donielle McCutcheon and Meghan F. Weinberg (Healthcare); Scott J.F. Goldstein (Insurance); Carla G. Teodoro (Investment Funds); Eric Kauffman (Labor and Employment); Ash Nagdev (Privacy and Cybersecurity); Keith Hayden Del Prete and Samuel Deddeh (Real Estate); and Idan Netser and Alvin Wang (Tax).
Article Author
Unknown Author
The Sponsor
